Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report

Table 1 Timeline

Time	Symptom development, diagnosis, and treatments
Week 1	Received increased dose of olanzapine
	Developed symptoms of NMS, such as fever, restlessness and rigidity
	Antipsychotic medication was stopped
	Noted to have raised CK level and severe AKI. Diagnosed to have NMS
	AKI failed to respond to intravenous hydration
	Hemodialysis started
Week 2	Intermittent hemodialysis needed
Week 3	Recovery of renal function and symptoms
Week 3	Discharged well with follow-up

AKI Acute kidney injury, CK creatinine kinase, NMS neuroleptic malignant syndrome

ISSN: 1752-1947